Financials

Related tickers

#NamePrice24h %7d %1M %1Y %Market CapLast 7 Days
4142
TLPH
Talphera, Inc. - Common Stock
1.41 USD-0.70%+20.51%+54.95%+235.71%73.18 M USD
4197
CTOR
Citius Oncology, Inc. - Common Stock
0.68 USD-2.86%-4.23%+3.03%-41.38%63.23 M USD
4315
SCYX
SCYNEXIS, Inc. - Common Stock
4.89 USD+9.15%+5.16%+15.06%+503.70%48.56 M USD
4397
IXHL
Incannex Healthcare Inc. - Common Stock
3.27 USD-1.21%-11.86%-15.50%+1208.00%39.12 M USD

Frequently asked questions about Intercure Ltd. - ordinary shares

What is the Intercure Ltd. - ordinary shares stock price today?

The current price of Intercure Ltd. - ordinary shares (INCR) is 0.98. Over the past 24 hours, the stock has changed by +3.16%. Follow the INCR chart for real-time price dynamics.

What is the stock ticker of Intercure Ltd. - ordinary shares?

Intercure Ltd. - ordinary shares trades under the ticker INCR. Tickers can differ by exchange, so always check the exchange and instrument details before trading.

Is Intercure Ltd. - ordinary shares stock going up?

INCR has changed by +1.03% over the last week, +8.89% over the last month, and -36.77% over the last year. Review the chart to see whether the current move is part of a broader trend.

How many employees does Intercure Ltd. - ordinary shares have?

As of the latest available data, Intercure Ltd. - ordinary shares has 285 employees. Workforce size can provide additional context about the company's scale and operations.

How can I buy Intercure Ltd. - ordinary shares stock?

You can buy Intercure Ltd. - ordinary shares (INCR) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.

Should I invest in Intercure Ltd. - ordinary shares stock?

Investing in Intercure Ltd. - ordinary shares requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the INCR chart and related analysis on metatrader.com as part of your research.

News